{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:24:25Z","timestamp":1790979865812,"version":"4.1.0"},"reference-count":29,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Dyskeratosis congenita (DC) is an inherited bone marrow failure disorder characterized by abnormal skin pigmentation and nail dystrophy. We have recently described, in 10 members of a large 3-generation family, an autosomal-dominant form of DC (AD DC) that is due to a mutation in the gene-encoding human telomerase RNA (TERC), resulting in telomere shortening. In studying the immunologic consequences of TERC mutations, severe B lymphopenia and decreased immunoglobulin M (IgM) levels were noted. T cells were found to overexpress senescent markers, including CD57 and Fas receptor, and were moderately reduced in cell number. To determine whether these in vivo findings were related to cellular replicative defects, short-term cultures of AD DC lymphocytes were established to measure proliferation, mitoses, and apoptosis. AD DC lymphocytes displayed a markedly reduced proliferative capacity and increased basal apoptotic rate. Finally, telomere shortening was most prominent in third-generation subjects, and there appeared to be a correlation between telomere length and in vivo and in vitro immune findings. In summary, the observed lymphopenia and hypogammaglobulinemia in AD DC is likely a consequence of replicative failure and premature senescence of lymphocytes, supporting a role of telomerase activity in immune homeostasis.<\/jats:p>","DOI":"10.1182\/blood-2004-04-1673","type":"journal-article","created":{"date-parts":[[2004,7,7]],"date-time":"2004-07-07T01:03:13Z","timestamp":1089162193000},"page":"682-688","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":76,"title":["Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita"],"prefix":"10.1182","volume":"105","author":[{"given":"Matt","family":"Knudson","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA; Department of Internal Medicine, Washington University School of Medicine, St Louis, MO; and Department of Internal Medicine, University of Iowa Hospitals and Clinics and the Iowa City Veterans Affairs Medical Center, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikant","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA; Department of Internal Medicine, Washington University School of Medicine, St Louis, MO; and Department of Internal Medicine, University of Iowa Hospitals and Clinics and the Iowa City Veterans Affairs Medical Center, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhair K.","family":"Ballas","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA; Department of Internal Medicine, Washington University School of Medicine, St Louis, MO; and Department of Internal Medicine, University of Iowa Hospitals and Clinics and the Iowa City Veterans Affairs Medical Center, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bessler","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA; Department of Internal Medicine, Washington University School of Medicine, St Louis, MO; and Department of Internal Medicine, University of Iowa Hospitals and Clinics and the Iowa City Veterans Affairs Medical Center, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Goldman","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA; Department of Internal Medicine, Washington University School of Medicine, St Louis, MO; and Department of Internal Medicine, University of Iowa Hospitals and Clinics and the Iowa City Veterans Affairs Medical Center, Iowa City, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222334008600_REF1","doi-asserted-by":"crossref","unstructured":"Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413: 432-435.","DOI":"10.1038\/35096585"},{"key":"2020021222334008600_REF2","doi-asserted-by":"crossref","unstructured":"Bree RT, Stenson-Cox C, Grealy M, Byrnes L, Gorman AM, Samali A. Cellular longevity: role of apoptosis and replicative senescence. Biogerontology. 2002;3: 195-206.","DOI":"10.1023\/A:1016299812327"},{"key":"2020021222334008600_REF3","doi-asserted-by":"crossref","unstructured":"Roth A, Yssel H, Pene J, et al. Telomerase levels control the lifespan of human T lymphocytes. Blood. 2003;102: 849-857.","DOI":"10.1182\/blood-2002-07-2015"},{"key":"2020021222334008600_REF4","doi-asserted-by":"crossref","unstructured":"Vulliamy TJ, Knight SW, Mason PJ, Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis. 2001;27: 353-357.","DOI":"10.1006\/bcmd.2001.0389"},{"key":"2020021222334008600_REF5","doi-asserted-by":"crossref","unstructured":"Solder B, Weiss M, Jager A, Belohradsky BH. Dyskeratosis congenita: multisystemic disorder with special consideration of immunologic aspects: a review of the literature. Clin Pediatr (Phila). 1998;37: 521-530.","DOI":"10.1177\/000992289803700901"},{"key":"2020021222334008600_REF6","doi-asserted-by":"crossref","unstructured":"Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110: 768-779.","DOI":"10.1046\/j.1365-2141.2000.02109.x"},{"key":"2020021222334008600_REF7","doi-asserted-by":"crossref","unstructured":"Knight SW, Heiss NS, Vulliamy TJ, et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol. 1999;107: 335-339.","DOI":"10.1046\/j.1365-2141.1999.01690.x"},{"key":"2020021222334008600_REF8","doi-asserted-by":"crossref","unstructured":"Ruggero D, Grisendi S, Piazza F, et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science. 2003;299: 259-262.","DOI":"10.1126\/science.1079447"},{"key":"2020021222334008600_REF9","doi-asserted-by":"crossref","unstructured":"Herrera E, Martinez A, Blasco MA. Impaired germinal center reaction in mice with short telomeres. EMBO J. 2000;19: 472-481.","DOI":"10.1093\/emboj\/19.3.472"},{"key":"2020021222334008600_REF10","doi-asserted-by":"crossref","unstructured":"Kinet S, Bernard F, Mongellaz C, Perreau M, Goldman FD, Taylor N. gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4(+) lymphocytes. Blood. 2002; 100: 2546-2553.","DOI":"10.1182\/blood-2002-03-0819"},{"key":"2020021222334008600_REF11","doi-asserted-by":"crossref","unstructured":"Goldman F, Gilman A, Hollenback C, et al. Hydroxychloroquine inhibits calcium signals in T cells, a new mechanism to explain its immunomodulatory properties. Blood. 2000;95: 3460-3466.","DOI":"10.1182\/blood.V95.11.3460"},{"key":"2020021222334008600_REF12","doi-asserted-by":"crossref","unstructured":"Goldman FD, Ballas ZK, Schutte BC, et al. Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest. 1998; 102: 421-429.","DOI":"10.1172\/JCI3205"},{"key":"2020021222334008600_REF13","doi-asserted-by":"crossref","unstructured":"Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol. 2002;2: 699-706.","DOI":"10.1038\/nri890"},{"key":"2020021222334008600_REF14","doi-asserted-by":"crossref","unstructured":"Cossu F, Vulliamy TJ, Marrone A, et al. A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK-SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. Br J Haeamtol. 2002;119: 765-768.","DOI":"10.1046\/j.1365-2141.2002.03822.x"},{"key":"2020021222334008600_REF15","doi-asserted-by":"crossref","unstructured":"Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91: 25-34.","DOI":"10.1016\/S0092-8674(01)80006-4"},{"key":"2020021222334008600_REF16","doi-asserted-by":"crossref","unstructured":"Mason PJ. Stem cells, telomerase and dyskeratosis congenita. Bioessays. 2003;25: 126-133.","DOI":"10.1002\/bies.10229"},{"key":"2020021222334008600_REF17","doi-asserted-by":"crossref","unstructured":"Vulliamy T, Marrone A, Szydlo R, et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004;36: 447-449.","DOI":"10.1038\/ng1346"},{"key":"2020021222334008600_REF18","doi-asserted-by":"crossref","unstructured":"Weng NP, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci U S A. 1997;94: 10827-10832.","DOI":"10.1073\/pnas.94.20.10827"},{"key":"2020021222334008600_REF19","doi-asserted-by":"crossref","unstructured":"Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A. 1992;89: 10114-10118.","DOI":"10.1073\/pnas.89.21.10114"},{"key":"2020021222334008600_REF20","doi-asserted-by":"crossref","unstructured":"Jung D, Neron S, Lemieux R, Roy A, Richard M. Telomere-independent reduction of human B lymphocyte: proliferation during long-term culture. Immunol Invest. 2001;30: 157-168.","DOI":"10.1081\/IMM-100104023"},{"key":"2020021222334008600_REF21","doi-asserted-by":"crossref","unstructured":"Weng NP, Levine BL, June CH, Hodes RJ. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci U S A. 1995;92: 11091-11094.","DOI":"10.1073\/pnas.92.24.11091"},{"key":"2020021222334008600_REF22","doi-asserted-by":"crossref","unstructured":"Hooijberg E, Ruizendaal JJ, Snijders PJ, Kueter EW, Walboomers JM, Spits H. Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase. J Immunol. 2000;165: 4239-4245.","DOI":"10.4049\/jimmunol.165.8.4239"},{"key":"2020021222334008600_REF23","doi-asserted-by":"crossref","unstructured":"Luiten RM, Pene J, Yssel H, Spits H. Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis. Blood. 2003;101: 4512-4519.","DOI":"10.1182\/blood-2002-07-2018"},{"key":"2020021222334008600_REF24","doi-asserted-by":"crossref","unstructured":"Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101: 2711-2720.","DOI":"10.1182\/blood-2002-07-2103"},{"key":"2020021222334008600_REF25","doi-asserted-by":"crossref","unstructured":"Kern F, Ode-Hakim S, Vogt K, Hoflich C, Reinke P, Volk HD. The enigma of CD57+. Clin Exp Immunol. 1996;104: 180-184.","DOI":"10.1046\/j.1365-2249.1996.d01-635.x"},{"key":"2020021222334008600_REF26","doi-asserted-by":"crossref","unstructured":"d'Angeac AD, Monier S, Pilling D, Travaglio-Encinoza A, Reme T, Salmon M. CD57+ T lymphocytes are derived from. Eur J Immunol. 1994;24: 1503-1511.","DOI":"10.1002\/eji.1830240707"},{"key":"2020021222334008600_REF27","doi-asserted-by":"crossref","unstructured":"Goldman FD, Vibhakar R, Puck JM, et al. Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome. Clin Immunol. 2002;104: 31-39.","DOI":"10.1006\/clim.2002.5249"},{"key":"2020021222334008600_REF28","unstructured":"Pereira-Smith O, Bertram M. Replicative senescence [abstract]. Generations. 2000;24: 43."},{"key":"2020021222334008600_REF29","doi-asserted-by":"crossref","unstructured":"Ren JG, Xia HL, Tian YM, Just T, Cai GP, Dai YR. Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett. 2001;488: 133-138.","DOI":"10.1016\/S0014-5793(00)02397-8"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/2\/682\/1705370\/zh800205000682.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/2\/682\/1705370\/zh800205000682.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T03:33:51Z","timestamp":1581564831000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/2\/682\/20060\/Association-of-immune-abnormalities-with-telomere"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,15]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-04-1673","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,15]]}}}